CUV 3.92% $15.65 clinuvel pharmaceuticals limited

Ann: CUV Appendix 4D Half Year Report, page-27

  1. 1,045 Posts.
    lightbulb Created with Sketch. 195
    PE of ~50 with an expansive upcoming R&D to produce new product lines. Great company just very.......expensive.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.